top of page

State lawmakers take up bills aiming to ‘revolutionize the insulin market’

By Mark Sanchez

Lawmakers in Lansing began considering bills last week that would allow the state to partner with a private manufacturer to produce and distribute low-cost generic insulin. 

The state House Health Policy Committee heard testimony from the backers of two bills that would require the Michigan Strategic Fund to create an insulin production program and offer $150 million to help develop a manufacturing facility. 


bottom of page